MedTrace Logo

Colorectal Cancer in Crohn's Disease

NCT04654494 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2020-12-08

No results posted yet for this study

Summary

Retrospective multicentre study. All patients with a diagnosis of Crohn's disease (CD) and operated for colorectal cancer (CRC) between 01/01/2010 and 01/01/2020 will be included in the dataset.

Data will include preoperative, intraoperative and postoperative variables, with long term follow up when feasible.

The study will focus on a comparison between patients treated with total proctocolectomy (TPC) and patients treated with subtotal colectomy (STC) or segmental resection (SR).

Primary endpoints will be oncologic outcomes, postoperative morbidity and mortality. Secondary endpoints include quality of life (QoL).

Conditions

Interventions

PROCEDURE

Total proctocolectomy

excision of the whole large bowel including colon and rectum and end ileostomy fashioning

PROCEDURE

Total colectomy

excision of the colon with preservation of the rectum

PROCEDURE

Segmental colectomy

excision of a segment of colon

Sponsors & Collaborators

  • University of Rome Tor Vergata

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-01
Primary Completion
2021-01-31
Completion
2021-01-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04654494 on ClinicalTrials.gov